|
Task Force for the HHS Diagnostic Prize for Antibacterial Resistance
|
Committee, Work group, Advisory group, or Task Force
|
FDA, OS
|
OD/OSP
|
Development of a Federal prize contest for a rapid diagnostic to identify drug-resistant bacterial infections.
|
|
Task Force on Environmental Health Risks and Safety Risks to Children: Coordinated Federal Action Plan to Reduce Racial and Ethnic Asthma Disparities
|
Committee, Work group, Advisory group, or Task Force
|
ACF, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG
|
NHLBI, NCMHD, NIAID, NICHD, NIEHS, NINR
|
The Action Plan to Reduce Asthma Disparities promotes collaboration and coordination among Federal agencies to leverage existing resources to address the multi-leveled causes of asthma disparities. The Action Plan outlines four key strategies to improve the quality of care for children who have asthma and promote community programs and resources to support clinicians, children, and their families in following best practices for asthma management.
|
|
TB Therapeutics Research Coordination Forum
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
NIAID
|
The purpose of the TB (Tuberculosis) Therapeutics Research Coordination Forum (“the Forum”) is to support and sustain discussion, information sharing, and decision making to coordinate clinical trials of new TB drug combinations. The overall goal is to advance new therapies rapidly and cost-effectively while maintaining the highest standards of scientific rigor. The Forum will work to coordinate planning among the major non-commercial sponsors and their research groups to ensure rapid and efficient Phase II evaluations of drug combinations.
|
|
Technical and Clinical Consultation to Indian Health Service in Kidney Disease
|
Public Education Campaign
|
IHS
|
NIDDK
|
A National Institute of Diabetes and Digestive and Kidney Diseases senior staff member serves as Chief Clinical Consultant for Nephrology for the Indian Health Service.
|
|
Technical Consultation on Viral Hepatitis (HCV) Infection in Young Injection Drug Users
|
Meeting/ Workshop
|
CDC, OS, SAMHSA
|
NIDA, NIAID, NIDDK
|
This collaboration brings Federal and non-Federal clinician/researchers from academia, state public health departments and community together to present and discuss current research and other information on an emerging epidemic of viral hepatitis (HCV) infection in the 15-30 year group of Injection Drug Users (IDUs).
|
|
Technical Resources Assistance Center and Information Exchange (TRACIE)
|
Resource Development
|
OS
|
NLM
|
This activity is to develop the Technical Resources Assistance Center and Information Exchange (TRACIE), a resource center, database, and methodology for healthcare facilities and coalitions to obtain information and assistance in emergency preparedness and response.
|
|
Text 4 Baby Program Evaluation Technical Advisory Group
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, HRSA, OS, SAMHSA
|
NICHD
|
Formal program evaluation of the Text 4 Baby initiative, which provides health info to pregnant women and young mothers via text message. For FY2014 there was a no cost extension.
|
|
Text4baby
|
Public Education Campaign
|
ACF, AHRQ, CDC, CMS, HRSA, IHS, SAMHSA
|
NIDCR, NICHD, NIDA, NIDDK
|
Free health text messaging service for pregnant women and new mothers. Those who text "BABY" (or “BEBE” for Spanish) to 511411 receive weekly text messages, timed to their due date or their baby''s birth date through the baby’s first year. Messages, which have been vetted by both government and non-profit health experts, deal with topics such as nutrition, immunization, birth defect prevention, and oral health.
|
|
The CDC Dental, Oral, and Craniofacial Data Resource Center (DRC)
|
Resource Development
|
CDC
|
NIDCR
|
The CDC Dental, Oral, and Craniofacial Data Resource Center (DRC) is a publicly accessible database, query system, and survey catalog for population-based oral health surveys.
|
|
The Effect of Various Drugs on the Retina
|
Other
|
FDA
|
NEI
|
Using powerful in vivo imaging technology, it is possible to view the retina at the cellular level. This collaboration seeks to monitor changes to the retina for drugs that are known to cross the blood/retina barrier to better understand possible toxicity.
|